Bendamustine hydrochloride
HealthData.Gov
Updated Mar 23, 2026
About this dataset
Bendamustine Hydrochloride is a generic prescription drug, available as an injectable powder in 25 mg and 100 mg vials, administered intravenously. It's an alkylating agent used to treat certain blood cancers like chronic lymphocytic leukemia and non-Hodgkin lymphoma. Manufactured by Accord Healthcare, Inc. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Bendamustine hydrochloride
Access the FDA dataset for Bendamustine hydrochloride β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025